DONGYUE GROUP (00189) announced its financial performance for the year 2025, with a net profit attributable to shareholders of 1.642 billion yuan, representing a year-on-year increase of 102.5%.
Dongyue Group (00189) announced its annual performance for the year ending December 31, 2025, with revenue of 14.355 billion yuan, an increase of 1.2% year-on-year. The attributable net profit to owners of the company was 1.642 billion yuan, an increase of 102.5% year-on-year. Basic earnings per share were 0.98 yuan, and a final dividend of 0.30 Hong Kong dollars per share is proposed.
DONGYUE GROUP (00189) released its annual performance as of December 31, 2025, with revenue of 14.355 billion yuan (RMB, the same below), an increase of 1.2% compared to the previous year; the net profit attributable to owners of the company was 1.642 billion yuan, an increase of 102.5% year-on-year; basic earnings per share were 0.98 yuan, and a final dividend of 0.30 Hong Kong dollars per share is proposed.
During the reporting period, the market conditions of the group's various segments varied, and the changes in product prices also differed. As a result, the performance of each segment also showed significant differences. Among them, the refrigerant business segment was the best-performing segment of the group, while the fluorine-containing high molecular materials, dichloromethane, and caustic soda business segments saw a slight decline, and the organosilicon business segment recorded a loss.
2025 is a key year for the green development of the fluorosilicon chemical industry. With the changing market conditions, the landscape of various fluorosilicon chemical products is gradually becoming clearer. Among them, the main products of the group's refrigerant division, such as R22 and R32, saw a substantial price increase under the quota restriction policy. In this situation, the group grasped industry trends, closely followed policy guidance, optimized market allocation, conducted thorough communication with all market participants, made early arrangements for market changes, achieved excellent business performance, and laid a solid foundation for the future layout of the industry.
Furthermore, the group has always attached great importance to independent research and development, insisting that independent research and development also help the group maintain long-term competitiveness in the market. During the reporting period, the group's research and development costs were approximately 784 million yuan, an increase of 10.93% year-on-year, with a further increase in the proportion of high-end new products. In the current year, the group also focused on improving production efficiency and energy conservation goals, completing more than 80 transformation projects through a series of innovative measures such as technological transformation, equipment upgrades, and process optimization to further reduce costs and increase efficiency. By the end of 2025, the group's research and development team had grown to over 370 people, with over 50% holding doctoral and master's degrees. During the year, the group obtained 60 patent authorizations, and the total number of patented patents at the end of the year reached 874, including 751 invention patents and 123 utility model patents. Additionally, the group formulated 7 standards during the reporting period, including 5 national standards and 2 industry standards, further promoting industry development.
Related Articles

ZJLD (06979) nominated Tang Xiangyang as an executive director.

BAIC MOTOR (01958): Terminate A-share listing counseling.

YH ENT (02306) recommends adopting the 2026 stock incentive plan.
ZJLD (06979) nominated Tang Xiangyang as an executive director.

BAIC MOTOR (01958): Terminate A-share listing counseling.

YH ENT (02306) recommends adopting the 2026 stock incentive plan.






